TrialPloS one2012

Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.

Cheng Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.